acoramidis ATTR investigational
Selected indexed studies
- Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications. (Pharmacotherapy, 2025) [PMID:39714070]
- Current and Future Treatment Landscape of Transthyretin Amyloid Cardiomyopathy. (Cardiol Ther, 2025) [PMID:40684004]
- Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy. (Heart Fail Rev, 2025) [PMID:40056371]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy. (2025) pubmed
- Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications. (2025) pubmed
- Current and Future Treatment Landscape of Transthyretin Amyloid Cardiomyopathy. (2025) pubmed
- Overview of Current and Emerging Therapies for Amyloid Transthyretin Cardiomyopathy. (2022) pubmed
- Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. (2024) pubmed